⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
IPSC News
Century Therapeutics, Inc. Common Stock
Form 8-K
sec.gov
IPSC
Form 8-K
sec.gov
IPSC
Century Therapeutics Reports Full Year 2025 Financial Results and Business Updates
globenewswire.com
IPSC
Century Therapeutics to Participate in Upcoming Investor Conferences in March
globenewswire.com
IPSC
Century Therapeutics Secures Oversubscribed $135 Million Private Placement Financing to Support Lead Program, CNTY-813, a Potentially Curative Therapy for Type 1 Diabetes
globenewswire.com
IPSC
Century Therapeutics Appoints Accomplished Biotechnology Leaders Dr. Han Lee and Dr. Martin Murphy to Board of Directors
globenewswire.com
IPSC
Century Therapeutics to Participate in Piper Sandler 37th Annual Healthcare Conference
globenewswire.com
IPSC
Century Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update
globenewswire.com
IPSC
Century Therapeutics Announces New Beta Islet Program for Type 1 Diabetes
globenewswire.com
IPSC
Century Therapeutics to Present at Chardan’s 9th Annual Genetic Medicines Conference
globenewswire.com
IPSC